Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
US NSCLC COMPETITIVE INTELLIGENCE
US NSCLC COMPETITIVE INTELLIGENCE
Pembrolizumab holds an estimated 52% share of first-line NSCLC, splitting the market into three PD-L1 cohorts ahead of its 2028 patent expiry.
Four approved...
